Corrigendum 20/january 19, 2015 2015 Relative Resolution No. Alregime Of New Listings And The Selling Price Of The Medicine For Usoumano «Simponi (Golimumab) Programme, The European Commission's Centralizzataeuropea Procedure Is Authorised. (Determin...

Original Language Title: Rettifica della determina n. 20/2015 del 19 gennaio 2015 relativa alregime di rimborsabilita' e prezzo di vendita del medicinale per usoumano «Simponi (golimumab)», autorizzata con procedura centralizzataeuropea della Commissione europea. (Determin...

Read the untranslated law here: http://www.gazzettaufficiale.it/atto/serie_generale/caricaArticoloDefault/originario?atto.dataPubblicazioneGazzetta=2015-03-03&atto.codiceRedazionale=15A01466&elenco30giorni=false&atto.tipoProvvedimento=DECRETO

The DIRECTOR-GENERAL having regard to determination no. 20/2015 of January 19, 2015 concerning the medicinal product for human use SIMPONI (golimumab) published in the official journal-General series-# 22 of January 28, 2015; Considered the documentation to this Office;
Grinding in art. 3 (for the purpose of Classification) where it is written: for the therapeutic indications rheumatoid arthritis (RA), psoriatic arthritis (AP), ankylosing spondylitis (SA): rheumatologist; Read: therapeutic indications for rheumatoid arthritis (RA), psoriatic arthritis (AP), ankylosing spondylitis (SA): rheumatologist, internist;
Rome, February 11, 2015 Director General: Pani